Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c064572ed025530a4d1c12769721aa1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4a49f13fe14672cc01f86f92f54d749 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00a1e8b68e34dc4fc7e9481afcf12ab0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3cab8ecdc75a593e3f9b9f6e2e5a31d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-708 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate |
2007-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6fbb2de19590b7fb3a7d7692b61ab1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18d8e8123cacd88f70701cc2a42030b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c84b5ba677dd6a23cda6a08f057e63dc |
publicationDate |
2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8227190-B2 |
titleOfInvention |
Approach to molecular diagnosis of human papillomavirus-related diseases |
abstract |
The present invention relates to an accurate, sensitive, and efficient sequential or concurrently sequential method for molecular diagnosis of human papillomavirus (HPV)-based disease, where the method improves the accuracy and reliability of diagnostic and prognostic assessments of HPV-based disease. The method of the invention comprises a primary screen of a sample for HPV nucleic acids, followed by a secondary screen for molecular markers, such as proliferation and cell cycle control group protein markers. The sequential or concurrently sequential method significantly reduces the number of false positive results. |
priorityDate |
2003-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |